A new pill called Enlicitide from Merck offers hope for cholesterol management. This first-ever oral PCSK9 inhibitor demonstrated substantial LDL reductions in a recent trial. It works alongside statins to lower bad cholesterol. This development could be a breakthrough for patients needing more effective treatment options.New pill cuts bad cholesterol by 60 percent: Could it become a game-changer in heart attack prevention?
A new pill called Enlicitide from Merck offers hope for cholesterol management. This first-ever oral PCSK9 inhibitor demonstrated substantial LDL reductions in a recent trial. It works alongside statins to lower bad cholesterol. This development could be a breakthrough for patients needing more effective treatment options.
